Phase 2 open-label, multicenter, single-arm study of cemiplimab in patients with locally advanced basal cell carcinoma after hedgehog inhibitor therapy: Extended follow-up
Journal of the American Academy of Dermatology（2024）
关键词
cemiplimab,clinical trial,hedgehog inhibitor,immune checkpoint inhibitor,locally advanced basal cell carcinoma,phase 2,quality of life
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要